These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7801142)

  • 1. Clinical relevance of granulocyte-macrophage colony-stimulating factor.
    Engelhard M; Brittinger G
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):1-4. PubMed ID: 7801142
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukine studies move forward.
    Vazquez E
    Posit Aware; 1999; 10(4):29. PubMed ID: 11366803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-mobilized peripheral blood progenitor cells.
    Nemunaitis J
    Semin Oncol; 1996 Apr; 23(2 Suppl 4):9-14. PubMed ID: 8600547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine therapy after bone marrow transplantation.
    Dix SP; Gilmore CE
    Pharmacotherapy; 1996; 16(4):593-608. PubMed ID: 8840365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
    Fisher DC; Peters WP
    Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?
    Croockewit AJ; Koopmans PP; de Pauw BE
    Clin Pharmacol Ther; 1996 Jan; 59(1):1-6. PubMed ID: 8549028
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials referral resource. NCI-sponsored trials of PIXY321.
    Miller LL; Cheson BD; Phillips P
    Oncology (Williston Park); 1993 Aug; 7(8):56, 62. PubMed ID: 8398635
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant human erythropoietin in combination with other hematopoietic cytokines in attenuating chemotherapy-induced multilineage myelosuppression: brief communication.
    Vadhan-Raj S
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):16-8. PubMed ID: 8714611
    [No Abstract]   [Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor in the treatment of small cell lung cancer.
    Wolf M; Klausmann M; Havemann K
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):51-6. PubMed ID: 7801147
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
    Barge AJ
    Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
    Wilson RF; Henry TD
    J Am Coll Cardiol; 2005 Nov; 46(9):1649-50. PubMed ID: 16256863
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for the use of granulocyte-macrophage colony-stimulating factor in oncology.
    Aglietta M; Piacibello W; Pasquino P; Sanavio F; Stacchini A; Volta C; Monteverde A; Fubini L; Morelli S; Severino A
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):5-9. PubMed ID: 7801146
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in cytokine production during therapy with granulocyte-macrophage colony-stimulating factor in patients with chronic hepatitis B.
    Martín J; Quiroga JA; Bosch O; Carreño V
    Hepatology; 1994 Nov; 20(5):1156-61. PubMed ID: 7927247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors in allogeneic transplantation.
    Nemunaitis J
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):96-101. PubMed ID: 8211221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian meta-analysis of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in children with cancer.
    Sung L; Beyene J; Hayden J; Nathan PC; Lange B; Tomlinson GA
    Am J Epidemiol; 2006 May; 163(9):811-7. PubMed ID: 16554346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.
    Page B; Morin MP; Mamzer MF; Thervet E; Legendre C
    Transplant Proc; 1994 Feb; 26(1):283. PubMed ID: 8108982
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Rüther U; Metzner B; Illiger HJ; Clemm C; Siegert W; Link H; Ostermann H; Schmoll HJ
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):57-63. PubMed ID: 7801148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.